动态或固定FDG-PET疾病指标对接受自体造血干细胞移植的复发/难治性弥漫大B细胞淋巴瘤患者是否具有更大预后价值?
该研究纳入125例接受挽救性免疫化疗及自体造血干细胞移植的复发/难治性弥漫大B细胞淋巴瘤患者,其中80例有挽救前PET、90例有移植前PET。中位随访5.6年,5年无进展生存率和总生存率分别为52%和65%。对于挽救治疗后PET阳性的残留病变患者,移植前平均肿瘤体积和最大标准化摄取值是显著的阴性预后因素,而挽救前指标及两次扫描间的变化与生存无关。
要点
- 移植前MTV每增加100ml,PFS的HR为1.19(p<0.001),OS的HR为1.78(p<0.001)。
- 移植前SUVmax与PFS(HR 1.08,p<0.001)和OS(HR 1.08,p<0.001)负相关。
- 挽救前MTV、SUVmax及∆MTV、∆SUVmax与PFS或OS无关。
核心结论
- 移植前MTV和SUVmax似乎比缓解程度具有更大的预测价值。
- 可能存在于PET指导的复发/难治性弥漫大B细胞淋巴瘤患者管理中的应用。
研究设计与样本
- 研究纳入125例接受挽救性免疫化疗和自体造血干细胞移植的复发/难治性弥漫大B细胞淋巴瘤患者。
- 80例有挽救前PET可用,90例有移植前PET可用。
主要发现
- 中位随访5.6年,5年无进展生存率为52%,总生存率为65%。
- 对于挽救治疗后PET阳性的残留病变患者,移植前MTV对PFS有显著阴性预后价值(HR 1.19每100ml,p<0.001),对OS亦有显著阴性预后价值(HR 1.78每100ml,p<0.001)。
- 移植前SUVmax与PFS负相关(HR 1.08,p<0.001),与OS负相关(HR 1.08,p<0.001)。
- 挽救前MTV和SUVmax以及∆MTV和∆SUVmax与PFS或OS无关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Positron emission tomography (PET) response assessment using the Deauville score has prognostic utility in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) undergoing autologous stem-cell transplantation (ASCT). Improved predictive methods are required to identify patients with poor outcomes who may be better considered for other salvage options. We investigated the prognostic value of mean tumour volume (MTV) and maximum standardised uptake value (SUVmax) at pre-salvage and pre-ASCT time-points, and the quantitative changes between scans (∆MTV and ∆SUVmax). One hundred and twenty-five patients with R/R DLBCL underwent salvage immunochemotherapy and ASCT: 80 patients had pre-salvage PET and 90 had pre-ASCT PET available. With a median follow-up of 5.6 years, 5-year progression-free survival (PFS) and overall survival (OS) were 52% and 65%, respectively. For patients with PET-positive residual disease after salvage therapy, pre-ASCT MTV was a significant negative prognosticator for PFS (HR 1.19 per 100 ml, p < 0.001) and OS (HR 1.78 per 100 ml, p < 0.001). Similarly, pre-ASCT SUVmax was negatively associated with PFS (HR 1.08, p < 0.001) and OS (HR 1.08, p < 0.001). Notably, pre-salvage MTV and SUVmax and ∆MTV and ∆SUVmax were not associated with PFS or OS. In conclusion, pre-ASCT MTV and SUVmax appear to be of greater predictive value than the degree of response. Potential application may exist for PET-directed management of R/R DLBCL patients.
引用
- Campbell BA, Brown R, Lambertini A, et al. Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation? Br J Haematol. 2023. PMID: 37015002. doi:10.1111/bjh.18644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。